Revenue, last quarter
$1.6M
−3.7% vs same quarter last year
Net income
−$56.9M
−29.9% vs same quarter last year
EPS, diluted
−$0.64
−12.3% vs same quarter last year
Operating cash flow
−$47.7M
−22.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $4M | −$161M |
| FY24 | $1.1M | −$88M |
| FY23 | $204K | −$48.6M |
| FY22 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −4722.1% | −3985.1% |
| FY24 | −10067.3% | −7729.6% |
| FY23 | −27180.9% | −23827% |
| FY22 | - | - |
- CG Oncology
- Healthcare median
Show the numbers
| Year | CG Oncology | Healthcare median |
|---|---|---|
| FY25 | −3985.1% | −30.6% |
| FY24 | −7729.6% | −47% |
| FY23 | −23827% | −58% |
| FY22 | - | −80.4% |